Group One Trading’s Immunome IMNM Stock Holding History

Group One Trading’s Portfolio IMNM Stock Details IMNM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$38.1K	Sell	1,800 -400	-18%	-$8.56K	﹤0.01%	5572
2026 Q1	$48.1K	Sell	2,200 -7,300	-77%	-$162K	﹤0.01%	5286
2025 Q4	$204K	Buy	9,500 +6,500	+217%	+$114K	﹤0.01%	4352
2025 Q3	$35.1K	Sell	3,000 -1,800	-38%	-$17.9K	﹤0.01%	6240
2025 Q2	$44.6K	Buy	4,800 +2,300	+92%	+$18.9K	﹤0.01%	5673
2025 Q1	$16.8K	Buy	2,500 +800	+47%	+$7.67K	﹤0.01%	5934
2024 Q4	$18.1K	Sell	1,700 -13,400	-89%	-$162K	﹤0.01%	5762
2024 Q3	$221K	Buy	15,100 +14,900	+7,450%	+$212K	﹤0.01%	3521
2024 Q2	$2.42K	Buy	+200	New	+$3.13K	﹤0.01%	6168
2023 Q3	–	Sell	-100	Closed	-$791	–	7933
2023 Q2	$791	Buy	+100	New	+$547	﹤0.01%	7308
2021 Q4	–	Sell	-100	Closed	-$2K	–	8485
2021 Q3	$2K	Buy	+100	New	+$1.74K	﹤0.01%	7937

Other funds holding IMNM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

Group One Trading's IMNM Position: Q2 2026 in Review

Group One Trading opened a new position in Immunome (IMNM) in Q2 2026: 7 shares worth $148. The stake represents ﹤0.01% of the portfolio and ranks #7386 among its holdings. This is a return to the name: Group One Trading previously reported a position in IMNM as recently as Q4 2025.

Group One Trading first reported a position in IMNM in Q2 2022 and has held it in 11 quarters since. The position peaked at $494K in Q4 2025. 203 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

Group One Trading held 7 shares of Immunome worth $148 as of Q2 2026.
Immunome was a new Group One Trading position in Q2 2026.
Immunome made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #7386 holding.
Group One Trading first reported a position in Immunome in Q2 2022 and has held it in 11 quarters since.
Group One Trading's Immunome position peaked at $494K in Q4 2025.
203 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.